Prof Dr E.G. Elisabeth de Vries, MD, PhD is Professor of Medical Oncology at the University Medical Centre Groningen, Groningen, the Netherlands. She is involved in patient care, teaching and research. Her research lines are aimed at increasing the sensitivity of tumours to anticancer drugs, and she uses imaging techniques to support this.

Apart from laboratory studies, she performs and coordinates clinical trials. She has received various grants, including grants from the Dutch Cancer Society, EU and an ERC advanced grant. She has supervised several PhD students and published numerous PubMed listed papers. She is currently Chairperson of the Committee for the new RECIST 2.0 version on behalf of the EORTC.

In 2002, she was appointed as a member of the Royal Academy of Arts and Sciences (KNAW). She received the European Society for Medical Oncology (ESMO) award in 2009. She is Fellow of the European Academy of Cancer Sciences and member of the Governing Body European Academy of Cancer Sciences since 2010. She was awarded a Royal Netherlands Academy of Sciences professorship in 2011.

She is currently the ESMO Cancer Medicines Committee Chair (2018-2019), the ESMO-Magnitude of Clinical Benefit Scale Working Group Chair (2016 - 2019) and also serves as a member of ESMO Council.